TUSC2: A Potential Drug Target for Cancer and Other Diseases (G11334)

Target Name: TUSC2

NCBI ID: G11334

TUSC2

TUSC2: A Potential Drug Target for Cancer and Other Diseases

TUSC2 (Tumor suppressor gene 2) is a gene that has been identified as a potential drug target for various diseases, including cancer. It is a transmembrane protein that is expressed in a variety of tissues, including the brain, pancreas, and skin. TUSC2 has been shown to play a role in several cellular processes, including cell signaling, angiogenesis, and inflammation.

One of the key functions of TUSC2 is its role as a tumor suppressor gene. TUSC2 has been shown to suppress the growth and survival of cancer cells, both in cell culture and in animal models of cancer. This is achieved through several mechanisms, including the inhibition of cell signaling pathways that promote cell growth and the inhibition of angiogenesis, the formation of new blood vessels that can support the growth of cancer cells.

Another function of TUSC2 is its role in cell signaling. TUSC2 has been shown to play a role in several signaling pathways that regulate cell behavior, including the signaling pathway that regulates cell growth, the signaling pathway that regulates cell differentiation, and the signaling pathway that regulates cell survival.

TUSC2 has also been shown to play a role in the development and progression of several diseases, including cancer. For example, TUSC2 has been shown to be downregulated in several types of cancer, including breast, ovarian, and prostate cancer. This downregulation has been shown to contribute to the development and progression of these cancers.

In addition to its role as a tumor suppressor gene, TUSC2 has also been shown to be a potential biomarker for several diseases, including cancer. This is because TUSC2 has been shown to be expressed in a variety of tissues and can be used as a protein that can be measured and used as a biomarker for certain diseases.

One of the challenges in studying TUSC2 as a drug target is the complexity of its functions and the difficulty of predicting how it will interact with small molecules. However, research into TUSC2 has identified several potential drug targets that may be involved in its function as a drug target.

One potential drug target for TUSC2 is the PI3K/Akt signaling pathway. This pathway is involved in cell signaling and has been shown to be involved in the development and progression of several diseases, including cancer. TUSC2 has been shown to interact with the PI3K/Akt signaling pathway and has been shown to play a role in the inhibition of this pathway. Therefore, drugs that target the PI3K/Akt signaling pathway may be effective in inhibiting the function of TUSC2 and may be a potential drug for TUSC2-related diseases.

Another potential drug target for TUSC2 is the TGF-β signaling pathway. This pathway is involved in cell signaling and has been shown to play a role in the development and progression of several diseases, including cancer. TUSC2 has been shown to interact with the TGF-β signaling pathway and has been shown to play a role in the inhibition of this pathway. Therefore, drugs that target the TGF-β signaling pathway may be effective in inhibiting the function of TUSC2 and may be a potential drug for TUSC2-related diseases.

In addition to these potential drug targets, TUSC2 may also be a potential biomarker for several diseases, including cancer. This is because TUSC2 has been shown to be expressed in a variety of tissues and can be used as a protein that can be measured and used as a biomarker for certain diseases.

Overall, TUSC2 is a gene that has been identified as a potential drug target for several diseases, including cancer. Its functions as a tumor suppressor gene and as a cell signaling pathway highlight its potential as a drug target. Further research is needed to fully understand the function of TUSC2 and to identify effective drugs that target its

Protein Name: Tumor Suppressor 2, Mitochondrial Calcium Regulator

Functions: May function as a tumor suppressor, inhibiting colony formation, causing G1 arrest and ultimately inducing apoptosis in homozygous 3p21.3 120-kb region-deficient cells

The "TUSC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TUSC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets